Hypersensitivity reactions to high osmolality Total Parenteral Nutrition: a case report.

Hypersensitivity reactions Osmolality Total Parenteral Nutrition Urticaria

Journal

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313

Informations de publication

Date de publication:
2019
Historique:
received: 25 06 2019
accepted: 21 08 2019
entrez: 6 9 2019
pubmed: 6 9 2019
medline: 6 9 2019
Statut: epublish

Résumé

The full range of allergic reactions to Total Parenteral Nutrition (TPN) remains unknown. Additionally, beyond individual allergens, there may be other factors contributing to TPN hypersensitivity reactions. We present a case of a patient with negative skin testing to common TPN allergens who had recurrent urticarial reactions to TPN. Her skin reactions resolved once TPN was stopped. Following a literature review, we postulated that the reactions could be due to the high osmolality of her TPN. Consequently, lowering her TPN from 2785 to 1928 mOsm/kg and premedicating with cetirizine resulted in resolution of her urticaria. When looking at patients who have hypersensitivity reactions to TPN, one must consider that their reactions may be due to factors other than allergens. More studies are needed to clarify the relationship between high osmolality TPN infusions and non-IgE mediated hypersensitivity reactions.

Sections du résumé

BACKGROUND BACKGROUND
The full range of allergic reactions to Total Parenteral Nutrition (TPN) remains unknown. Additionally, beyond individual allergens, there may be other factors contributing to TPN hypersensitivity reactions.
CASE PRESENTATION METHODS
We present a case of a patient with negative skin testing to common TPN allergens who had recurrent urticarial reactions to TPN. Her skin reactions resolved once TPN was stopped. Following a literature review, we postulated that the reactions could be due to the high osmolality of her TPN. Consequently, lowering her TPN from 2785 to 1928 mOsm/kg and premedicating with cetirizine resulted in resolution of her urticaria.
CONCLUSIONS CONCLUSIONS
When looking at patients who have hypersensitivity reactions to TPN, one must consider that their reactions may be due to factors other than allergens. More studies are needed to clarify the relationship between high osmolality TPN infusions and non-IgE mediated hypersensitivity reactions.

Identifiants

pubmed: 31485241
doi: 10.1186/s13223-019-0364-z
pii: 364
pmc: PMC6716805
doi:

Types de publication

Case Reports

Langues

eng

Pagination

51

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

AJR Am J Roentgenol. 2001 Jun;176(6):1385-8
pubmed: 11373197
AJR Am J Roentgenol. 1991 Apr;156(4):825-32
pubmed: 1825900
JPEN J Parenter Enteral Nutr. 2009 Nov-Dec;33(6):691-3
pubmed: 19892903
JPEN J Parenter Enteral Nutr. 2012 Jan;36(1):117-21
pubmed: 21965458
Acta Derm Venereol. 2015 Sep;95(7):854-5
pubmed: 25783746
Nutrition. 2016 Nov-Dec;32(11-12):1303-5
pubmed: 27349487
JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1222-1229
pubmed: 29761928
JPEN J Parenter Enteral Nutr. 1987 May-Jun;11(3):314-5
pubmed: 3110449
Surg Gynecol Obstet. 1985 Dec;161(6):535-40
pubmed: 3934777
N Engl J Med. 1974 Jul 18;291(3):134-5
pubmed: 4833927
JPEN J Parenter Enteral Nutr. 1984 Sep-Oct;8(5):546-51
pubmed: 6436529
Radiology. 1980 Nov;137(2):299-302
pubmed: 7433658
Surg Today. 1995;25(8):667-71
pubmed: 8520158
J Allergy Clin Immunol. 1979 Apr;63(4):281-8
pubmed: 85650
J Comput Assist Tomogr. 1998 May-Jun;22(3):341-5
pubmed: 9606371

Auteurs

Steph A Pang (SA)

1Faculty of Medicine, McGill University, 3655 Promenade Sir-William-Osler, Montreal, QC H3G 1Y6 Canada.

Shaun Eintracht (S)

2Division of Medical Biochemistry, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1E2 Canada.

Jesse M Schwartz (JM)

3Division of Allergy and Immunology, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1E2 Canada.

Belinda Lobo (B)

4Division of Clinical Nutrition, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1E2 Canada.

Elizabeth MacNamara (E)

2Division of Medical Biochemistry, Jewish General Hospital, 3755 Chemin de la Côte-Sainte-Catherine, Montreal, QC H3T 1E2 Canada.

Classifications MeSH